Human Fertilisation and Embryology Act 2008
Human Fertilisation and Embryology Act 2008
The Human Fertilisation and Embryology Act 2008 is a significant piece of legislation in the United Kingdom that amends the Human Fertilisation and Embryology Act 1990. The Act addresses various issues related to assisted reproductive technology, embryo research, and the regulation of fertility clinics.
Background[edit | edit source]
The original Human Fertilisation and Embryology Act 1990 was enacted to regulate the use of gametes and embryos in treatment and research. The 2008 Act was introduced to update the legal framework in response to advances in reproductive technology and changes in societal attitudes.
Key Provisions[edit | edit source]
The Human Fertilisation and Embryology Act 2008 includes several key provisions:
- **Regulation of Embryo Research**: The Act allows for the creation and use of human-animal hybrid embryos for research purposes under strict regulatory conditions.
- **Parental Orders**: The Act provides for the legal recognition of same-sex couples as parents of children born through surrogacy.
- **Storage Limits**: The Act extends the storage limits for gametes and embryos.
- **Welfare of the Child**: The Act emphasizes the consideration of the welfare of the child in decisions related to assisted reproduction.
Human Fertilisation and Embryology Authority[edit | edit source]
The Human Fertilisation and Embryology Authority (HFEA) is the regulatory body established to oversee the implementation of the Act. The HFEA is responsible for licensing and monitoring fertility clinics and research centers, ensuring compliance with the law.
Ethical Considerations[edit | edit source]
The Act addresses several ethical issues, including the use of pre-implantation genetic diagnosis (PGD) and savior siblings. It also sets out the conditions under which embryo research can be conducted, balancing scientific progress with ethical concerns.
Impact[edit | edit source]
The Human Fertilisation and Embryology Act 2008 has had a significant impact on the field of reproductive medicine and embryo research in the UK. It has provided a clear legal framework for the use of advanced reproductive technologies and has influenced similar legislation in other countries.
Amendments[edit | edit source]
The Act has been subject to various amendments to address emerging issues in reproductive technology and embryo research. These amendments ensure that the legislation remains relevant and effective in regulating the field.
See Also[edit | edit source]
- Assisted reproductive technology
- Embryo research
- Fertility clinic
- Human Fertilisation and Embryology Authority
- Human Fertilisation and Embryology Act 1990
- Pre-implantation genetic diagnosis
- Savior sibling
- Surrogacy
References[edit | edit source]
External Links[edit | edit source]
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD